These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8099620)

  • 1. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
    Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
    Paul IA; Nowak G; Layer RT; Popik P; Skolnick P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):95-102. PubMed ID: 8169857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic glycine treatment desensitizes the behavioral response to 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the strychnine-insensitive glycine site of the NMDA receptor complex.
    Nowak G; Li Y; Paul IA
    J Neural Transm (Vienna); 2000; 107(2):123-31. PubMed ID: 10847554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rise in zinc affinity for the NMDA receptor evoked by chronic imipramine is species-specific.
    Szewczyk B; Kata R; Nowak G
    Pol J Pharmacol; 2001; 53(6):641-5. PubMed ID: 11985339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.
    Paul IA; Layer RT; Skolnick P; Nowak G
    Eur J Pharmacol; 1993 Nov; 247(3):305-11. PubMed ID: 7905831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression.
    Nowak G; Ossowska G; Jopek R; Papp M
    Pol J Pharmacol; 1998; 50(4-5):365-9. PubMed ID: 10091723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NG-nitro-L-arginine on age-related changes of glutamate receptor systems and immunophilin in rats.
    Araki T; Oshima Y; Kato H; Shuto K; Itoyama Y
    Methods Find Exp Clin Pharmacol; 1997; 19(6):373-81. PubMed ID: 9385586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
    Javitt DC; Zukin SR
    Mol Pharmacol; 1989 Apr; 35(4):387-93. PubMed ID: 2468076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor binding in adult rat brain after several chronic ethanol treatment protocols.
    Rudolph JG; Walker DW; Iimuro Y; Thurman RG; Crews FT
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1508-19. PubMed ID: 9394125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
    Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
    Baron BM; Harrison BL; McDonald IA; Meldrum BS; Palfreyman MG; Salituro FG; Siegel BW; Slone AL; Turner JP; White HS
    J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of a glycine partial agonist alters the expression of N-methyl-D-aspartate receptor subunit mRNAs.
    Bovetto S; Boyer P; Skolnick P; Fossom LH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1503-8. PubMed ID: 9400027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims.
    Nowak G; Ordway GA; Paul IA
    Brain Res; 1995 Mar; 675(1-2):157-64. PubMed ID: 7796124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex.
    Nowak G
    Pol J Pharmacol; 1996; 48(2):137-43. PubMed ID: 9112643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1-methyl-4-phenylpyridinium on radioligand binding to the NMDA receptor complex.
    Sundström E; Mo LL
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):131-6. PubMed ID: 7670845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.